Beliefs of medicine questionnaire: Translation, validation, and adaptation for post-acute coronary syndrome patients in the south of Sulawesi population, Indonesia Authors: Zulkifli Halid, Dyah Aryani Perwitasari, Nanik Sulistyani, Imaniar Noor Faridah, lham Alifiar, Thang Nguyen, Robert Horne Published: 2026 ABSTRACT BackgroundPatients' perceptions of medication significantly influence therapeutic outcomes, particularly among individuals with Acute Coronary Syndrome (ACS). The Beliefs about Medicines Questionnaire (BMQ) is a widely utilized instrument for evaluating patients' beliefs regarding their medications. However, a validated, culturally relevant, and linguistically accurate Indonesian version of the BMQ is currently unavailable. The absence of such adaptation restricts the tool's effectiveness in assessing beliefs among post-ACS patients in Indonesia, where these beliefs may substantially impact treatment adherence and clinical outcomes. Therefore, translation, validation, and cultural adaptation of the BMQ are essential to ensure its accuracy in evaluating patient beliefs within the Indonesian context.PurposeTo develop and validate an Indonesian version of the BMQ questionnaire, ensuring its linguistic and cultural appropriateness for use specifically among post-ACS patients in Indonesia. This validated version is crucial for regions with a high burden of cardiovascular disease, where belief patterns can inform tailored adherence interventions.Patients and methodsThis cross-sectional study was conducted with post-acute coronary syndrome (ACS) patients who received treatment in June and July 2025 at two hospitals in Makassar, South Sulawesi, Indonesia. We adhered to the established guidelines for forward-backward translation and recruited 96 post-ACS outpatients. The inclusion criteria encompassed individuals aged ≥18 years who had been diagnosed with ACS, had undergone therapy for a minimum of six months, and had provided written consent to participate. The psychometric evaluation by Horne et al., comprised confirmatory factor analysis, item-total validity assessed through Pearson correlation, internal consistency measured using Cronbach's alpha, and inter-rater reliability.ResultsThe Indonesian-translated BMQ instrument was tested for validity and reliability among 96 post-ACS patients. All 18 items demonstrated strong validity with r-count values exceeding the r-table threshold (0.1996). Cronbach's alpha values were all ≥0.750 across domains, indicating high overall reliability. Pilot feedback prompted minor wording refinements to enhance clarity and cultural resonance. These results confirm that the instrument reliably measures patient beliefs about medicine in this population.ConclusionThe psychometric properties of the Indonesian version of the BMQ align with those documented in the original study. Our findings indicate that the Indonesian adaptation of the BMQ is a valid and reliable instrument for evaluating treatment-related beliefs in patients with post-acute coronary syndrome (ACS) in South Sulawesi, Indonesia. However, further psychometric assessments are necessary to confirm its broader applicability across different regions and patient populations, particularly in population-based studies and routine pharmacy practice settings. Introduction Acute Coronary Syndrome (ACS) is a non-communicable disease characterized by serious cardiovascular conditions with high mortality rates.1., 2, 3 ACS, as part of the spectrum of ischemic heart disease, continues to contribute substantially to global morbidity and mortality, remaining one of the most common causes of death worldwide.4 Studies consistently show that adherence to secondary prevention medications after ACS hospitalization is poor and declines over time, with a substantial proportion of patients discontinuing therapies within the first year after discharge.5, 6 Patients with ACS often have a heavier risk profile, leading to increased incidence, morbidity, and mortality.7, 8 One factor that requires attention is patients' beliefs or perceptions about the treatment they are undergoing.9 Patients perceptions or beliefs about treatment, medicine efficacy, and safety are also important factors in their decision to comply with the treatment plan. The necessity–concerns framework developed by Horne and Weinman (1999) emphasizes that patients' decisions to adhere to therapy are based on considerations between their belief in the need for medication and their concerns about potential side effects.10 Patients' beliefs about medication can significantly affect their adherence and clinical outcomes. Positive perceptions of treatment can increase patients' motivation to undergo prescribed therapy, while doubts or fears can contribute to non-compliance.11 Measuring patients' perceptions or beliefs about their treatment can be done using the Beliefs about Medicines Questionnaire (BMQ) developed by Horne et al. (1999).10 The BMQ consists of 18 questions, divided into two sections: BMQ-Specific (measures beliefs about medicines for specific diseases, including Specific-Necessity and Specific-Concerns), each with five questions, and BMQ-General (measures general views about medicines, including General-Harm and General-Overuse), each with four questions. The psychometric validity of the BMQ has been confirmed in various chronic conditions, including asthma, diabetes, hypertension, and cardiovascular disease.10, 12 However, the application of BMQ in various languages and cultural contexts cannot be achieved solely through literal translation. Patients perceptions of disease and medication are greatly influenced by cultural factors, including the role of family, spiritual beliefs, and traditional healing practices.13, 14 Indonesia is a multilingual country where Indonesian (Bahasa Indonesia), spoken by 98% of the population, serves as the lingua franca, making it the most effective language for broad health communication.15 Therefore, a systematic cross-cultural adaptation process involving forward-backward translation, review, and pilot testing is necessary, especially for the Indonesian language.16, 17 Several translations and validations have been conducted for this instrument, including those into Czech and Slovak,18 Portuguese,19 Swedish,20 Turkish21 and Indonesian, but it was used on pregnant women22 and in HIV outpatients.14 While the questionnaire has been validated for pregnant women and individuals with HIV, it is imperative to revalidate it for other populations, such as those with acute coronary syndrome (ACS), because of variations in health perceptions, medication use, and disease contexts. This revalidation ensures the continued relevance and accuracy of these results. Furthermore, this marks the inaugural translation of the questionnaire into Indonesian for patients with cardiovascular disease, specifically those with post-acute coronary syndrome (ACS), underscoring the necessity of its validation in this context.23 The BMQ contributes to clinical practice by enabling pharmacists to identify imbalances between necessity and concerns during medication reviews, thereby facilitating targeted adherence interventions within post-ACS care pathways. Patients' perceptions and beliefs about medications, as well as their involvement in their own treatment, highlight the importance of integrating their needs and the benefits of their medications. This approach may be key to improving perceptions and clinical outcomes in the ACS population.24 Tailored interventions that address patient concerns while emphasizing the importance of medication adherence may help reduce risks associated with ACS, particularly in vulnerable populations with heterogeneous responses to treatment.25 Studies using the BMQ consistently show that stronger beliefs in the need for medication and lower concerns about side effects are associated with better compliance.12, 26 In the cardiovascular population, patients with high beliefs about the necessity of treatment and low concerns were found to have significantly higher adherence to cardioprotective medications.27 A meta-analysis conducted by Foot et al. on more than 3000 patients with various conditions also showed that the difference between belief in necessity and concern (necessity–concerns differential/NCD) was a significant predictor of adherence (OR = 1.89, 95% CI: 1.71–2.09).12 Patients' beliefs about medicines (necessity vs. concerns) are known to influence adherence and outcomes after acute coronary syndrome (ACS). By translating and validating the Beliefs about Medicines Questionnaire (BMQ) for Indonesian ACS patients, this study addresses a clear gap and potentially enables better identification of patients at risk of non-adherence.28 Although the BMQ has been translated and validated in several languages, it has not yet been adapted and validated for the Indonesian context, particularly for post-ACS patients. The aim of this study is to translate, adapt, and validate the BMQ questionnaire for post-ACS at the cardiology and vascular polyclinic of two hospitals in Makassar, South Sulawesi, Indonesia. The adaptation process will ensure that the instrument accurately reflects the beliefs and concerns specific to this group. Validation, including statistical tests like criterion validity with Confirmatory Factor Analysis (CFA) and item-total validity assessed through Pearson correlation, internal consistency reliability using Cronbach alpha, will confirm the instrument's reliability and relevance in this context. This study's statistical rationale emphasizes the importance of these analyses in ensuring that the adapted BMQ provides accurate, culturally relevant data for the target population. Material and methods Instrument The Beliefs about Medicines Questionnaire (BMQ), developed by Horne and colleagues10 is an 18-item instrument designed to assess patients' beliefs about medicines. It comprises two specific subscales (Specific Necessity and Specific Concerns, five items each) and two general subscales (General Overuse and General Harm, four items each). Each item was rated on a five-point Likert scale ranging from “strongly disagree” (1) to “strongly agree” (5), with higher scores indicating stronger beliefs in the corresponding construct. Study design This study utilized a cross-sectional research design to examine outpatients with post-acute coronary syndrome (post-ACS). Five students from the Pharmacy Undergraduate Program, Faculty of Medicine and Health Sciences, University of Muhammadiyah Makassar, were trained as research assistants and supported data collection, pilot testing phase and respondent interviews at both hospitals. The ethical aspects of this research were reviewed and approved as ethically appropriate by the Research Ethics Committee of the Faculty of Medicine and Health Sciences, University of Muhammadiyah Makassar (Approval No. 548/UM.PKE/VIII/46/2024). The study adhered the principles outlined in the Declaration of Helsinki,29 and all participants provided informed consent. Respondents The target participants were patients with post-acute coronary syndrome (post-ACS) who received treatment at the cardiology and vascular polyclinic of two hospitals in Makassar, South Sulawesi, Indonesia, during June and July 2025. The inclusion criteria required respondents to be adults aged 18 years or older, to have undergone at least six months of therapy, to provide written informed consent, and to voluntarily agree to participate. Only individuals who met these criteria were included in the study. The sample size of respondents was five times (5:1) the number of items in the questionnaire,30, 31 so a minimum of 90 respondents were needed for this questionnaire. The study design followed the guidelines established for the validation, reliability and adaptation process.30, 32 Descriptive statistics were utilized to describe the patients' demographic characteristics and their questionnaire responses. Categorical variables were examined using frequencies and percentages. All statistical analyses were conducted using SPSS version 26. Forward-backward translation This study translated, adapted, and validated the BMQ questionnaire in post-ACS outpatients at two hospitals in Makassar, South Sulawesi, Indonesia. This process is illustrated in Fig. 1 (agreement number in biorender: NC28Q9Z9EK).Fig. 1Process of translating, adapting, and validating the Indonesian Beliefs about Medicines Questionnaire (BMQ), from forward–backward translation to expert review, pilot testing, and psychometric testing.Fig. 1 Process of translating, adapting, and validating the Indonesian Beliefs about Medicines Questionnaire (BMQ), from forward–backward translation to expert review, pilot testing, and psychometric testing. Following the best-practice stages aligned with Hall et al.,33 the translation and adaptation process was executed systematically, beginning with two independent forward translations by independent translators who produced separate Indonesian drafts. These drafts were then synthesised through a reconciliation meeting, which resulted in a harmonised version with documented decisions to ensure conceptual equivalence. Two native-level English speakers, blinded to the original instrument, subsequently performed back translations of the reconciled Indonesian version of the scale. Finally, an expert committee comprising a cardiologist, clinical pharmacist, and field coordinator reviewed the source, forward, and backward-translated versions to assess semantic, idiomatic, experiential, and conceptual equivalence. The results of the review were then continued to the pilot testing process. Adaptation/ pilot testing Pilot testing was conducted using n = 10 respondents to assess the comprehensibility of the translated instrument. Respondents completed the questionnaire, followed by semi-structured cognitive debriefing with open-ended questions regarding item clarity, cultural relevance, and response burden. The results of the pilot testing evaluation were then used as the basis for developing the final version of an optimal instrument that could be understood by both researchers and research subjects, ensuring the instrument was representative and relevant in the socio-cultural context of Indonesian society, particularly in Makassar, South Sulawesi, Indonesia. Feedback identifying three items with comprehension issues was analysed via content analysis, leading to minor wording refinements for the final version optimal for the Indonesian sociocultural context in Makassar. Data collection Data for the psychometric evaluation were collected using a paper-based questionnaire. For patients who were unable to independently complete the questionnaire, assistance was provided by researchers or family members, contingent on obtaining the patient's prior consent. Informed consent was obtained in a clear and transparent manner, ensuring that the patients fully understood the study's purpose and procedure. Patients who met the criteria but declined to participate in the study were recorded as refusals, which is essential for accurately calculating the response rate to enable rigorous assessment of selection bias. The questionnaires took approximately 5–10 min to complete. Validation and reliability of the questionnaire The tests included criterion validity testing and internal consistency reliability testing. Criterion validity testing was used to measure the extent to which the questionnaire correlated with the criteria, specifically the daily activities of post-ACS patients. Cronbach's alpha coefficient, denoted as alpha, was used to evaluate the internal consistency of the BMQ. This coefficient reflects the degree to which all items within the BMQ subscales measure the same construct, also referred to as the interrelatedness of items, thus ensuring reliability. Cronbach's alpha coefficient (α) ranges from 0 (indicating that items are independent) to 1 (indicating that items are perfectly correlated). A commonly accepted guideline suggests that a Cronbach's alpha (α) value ranging from 0.6 to 0.7 signifies an acceptable level of reliability, whereas a value of 0.8 or higher indicates a very good level of reliability.34 Construct validity was evaluated by examining the correlations between items within the same and across different domains, with the Kaiser-Meyer-Olkin (KMO) test applied to assess the statistical significance. Initially, the KMO measure of sampling adequacy and Bartlett's Test of Sphericity were applied to evaluate whether the dataset was suitable for factor analysis. A KMO value greater than 0.5 suggests that factor analysis is appropriate. Factor analysis was performed using a correlation matrix to identify the underlying subscales of the questionnaire. Items with factor loadings exceeding 0.40 were deemed significant contributors to a factor, aiding in the interpretation and labelling of the associated construct. To maintain consistency and uniformity among enumerators, an inter-rater reliability (IRR) test was conducted using Interclass Correlation Coefficient (ICC) analysis, ensuring that the translated and culturally adapted instrument was proven to be more reliable and free from individual bias.35, 36 ICC is a widely used reliability index in testretest, intrarater, and interrater reliability analyses.37 Results The primary objective of this study was to develop and validate an Indonesian version of the Beliefs about Medicines Questionnaire (BMQ) that accurately assesses patients' beliefs regarding medications within the local context. The resulting instrument is intended for use by healthcare practitioners, particularly pharmacists, to evaluate patients' beliefs about their medications and facilitate more targeted counseling and interventions aimed at enhancing medication use and adherence. The psychometric evaluation of the Indonesian version of the BMQ was conducted through a systematic process of translation, cultural adaptation, and validation of the original English instrument. A total of 101 eligible patients were invited to participate in this study. Of these, five declined because they did not wish to be interviewed, whereas the remaining 96 patients agreed to participate in the study, resulting in a response rate of 95.0% (96/101). These 96 respondents were selected using a non-probability sampling approach, and these data formed the basis for the subsequent validity and reliability analyses presented in the following sections. Descriptive statistics were used to detail the patient demographics and questionnaire responses. Demographic data Respondent demographic data, including gender, age, education level, marital status, ethnicity, body mass index (BMI), smoking history, alcohol consumption, use of traditional medicine, are presented in Table 1.Table 1Demographic characteristics of study sample.No.Demographic CharacteristicsResultsPercentage (%)1GenderMale4041.67Female5658.332Age≤ 44 years55.2145–64 years5153.12≥ 65 years4041.673EducationSD (Sekolah Dasar; Elementary School) / SM (Sekolah Menengah; Junior High/High School)6769.79Bachelor's/Master's/Doctorate2627.08No School33.134Marital StatusMarried7578.12Not Married66.25Widow/Widower1515.635EthnicityMakassar7477.08Bugis1616.67Others66.256BMI (Body Mass Index)Underweight4546.88Ideal2323.96Overweight1414.58Obese1414.587History of SmokingYes1919.79No7780.218History of Alcohol ConsumptionYes55.21No9194.799Consumption of Traditional MedicineYes2526.04No7173.96 Table 1Demographic characteristics of study sample.No.Demographic CharacteristicsResultsPercentage (%)1GenderMale4041.67Female5658.332Age≤ 44 years55.2145–64 years5153.12≥ 65 years4041.673EducationSD (Sekolah Dasar; Elementary School) / SM (Sekolah Menengah; Junior High/High School)6769.79Bachelor's/Master's/Doctorate2627.08No School33.134Marital StatusMarried7578.12Not Married66.25Widow/Widower1515.635EthnicityMakassar7477.08Bugis1616.67Others66.256BMI (Body Mass Index)Underweight4546.88Ideal2323.96Overweight1414.58Obese1414.587History of SmokingYes1919.79No7780.218History of Alcohol ConsumptionYes55.21No9194.799Consumption of Traditional MedicineYes2526.04No7173.96 Demographic characteristics of study sample. Translation and pilot testing of instruments The original BMQ questionnaire instrument in English was translated into Indonesian using the forward-backward translation method. After translation, adaptation and pilot testing confirmed that the Indonesian BMQ was culturally and contextually appropriate. Cross-cultural adaptation was conducted systematically after forward and backward translation to ensure both linguistic and conceptual equivalence.14, 32, 38 The results showed that some language and narratives were modified to ensure patients could understand the meaning of the statements in the translated instrument, with the pilot test results presented in Table 2.Table 2Forward-backward translation and pilot testing results.No.Original QuestionnaireForward TranslationBackward TranslationPilot Testing1.Specific necessity1.My life would be impossible without my medicines.2.Without my medicines, I would be very sick.3.My health, at present, depends on my medicines.4.My medicines protect me from becoming worse.5.My health in the future will depend on my medicines.Kebutuhan tertentu1. Hidup saya tidak akan mungkin tanpa obat obatan saya. 2. Tanpa obat-obatan, saya akan merasa sangat sakit 3. Kesehatan saya, saat ini, bergantung kepada obat-obatan saya 4. Obat-obatan saya melindungi saya dari menjadi lebih buruk 5. Kesehatan saya di masa depan akan bergantung pada obat-obatan saya Special concerns1.I sometimes worry about the longterm effects of my medications.2.Without the medicines, I would feel very ill3.My health at this time is dependent on my medicines4.My medications protect me from severity.5.My health in the future will depend on my medicationsKebutuhan tertentu1. Hidup saya tergantung pada obat obatan saya. 2. Tanpa obat-obatan, saya akan merasa sangat sakit. 3. Kesehatan saya, saat ini, bergantung kepada obat-obatan saya 4. Obat-obatan saya melindungi saya supaya tidak bertambah parah. 5. Kesehatan saya di masa depan akan bergantung pada obat-obatan saya 2.Specific concerns1.I sometimes worry about the long-term effects of my medicines.2.Having to take medicines worries me.3.I sometimes worry about becoming too dependent on my medicines.4.My medicines disrupt my life.5.My medicines are a mystery to me.Kekhawatiran tertentu1. Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya. 2. Keharusan minum obat membuat saya khawatir. 3. Saya terkadang khawatir menjadi sangat tergantung terhadap obat-obatan saya. 4. Obat-obatan saya menganggu kehidupan saya. 5. Obat-obatan saya adalah sebuah misteri bagi saya. Special concerns1.I sometimes worry about the long-term effects of my medications.2.Having to take medicine makes me worry.3.I am sometimes concerned about becoming highly dependent on my medicines.4.My medicines disrupt my life.5.My medicines are a mystery to me.Kekhawatiran tertentu1. Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya. 2. Saya khawatir karena harus minum obat. 3. Saya terkadang khawatir menjadi tergantung terhadap obat-obatan saya. 4. Obat-obatan saya menganggu kehidupan saya. 5. Saya sulit memahami obat-obatan sy. 3.General overuse1.If doctors had more time with patients, they would prescribe fewer medicines.2.Doctors use too many medicines.3.Doctors place too much trust in medicines.4.Natural remedies are safer than medicines.Penggunaan berlebihan secara umum1. Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, mereka akan meresepkan lebih sedikit obat obatan. 2. Dokter-dokter menggunakan terlalu banyak obat-obatan 3. Dokter-dokter terlalu percaya pada obat-obat 4. Pengobatan alami lebih aman dibandingkan obat-obatan Overuse1.If doctors had more time with patients, they would prescribe fewer medications.2.Doctors use too many medicines3.Doctors put too much trust in medications4.Natural treatments are safer than medicationsPenggunaan berlebihan secara umum1. Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, dokter akan meresepkan lebih sedikit obat. 2. Dokter terlalu banyak memberikan obat-obatan. 3. Dokter-dokter terlalu percaya pada obat-obat 4. Pengobatan alami lebih aman dibandingkan obat-obatan 4.General harm1.Medicines do more harm than good.2.People who take medicines should stop their treatment for a while every now and again.3.Most medicines are addictive4.All medicines are poisons.efek yang merugikan secara umum1. Obat-obatan lebih banyak merugikan daripada menguntungkan 2. Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang 3. Kebanyakan obat bersifat adiktif 4. Semua obat-obatan adalah racun Harmful effects in general1.Medicines do more harm than good2.People who take medications should stop their treatment for a while3.Most medicines are addictive4.All medicines are poisonsefek yang merugikan secara umum1.Obat-obatan lebih banyak merugikan daripada menguntungkan2.Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang3.Kebanyakan obat menyebabkan ketergantungan4.Semua obat-obatan adalah racun Table 2Forward-backward translation and pilot testing results.No.Original QuestionnaireForward TranslationBackward TranslationPilot Testing1.Specific necessity1.My life would be impossible without my medicines.2.Without my medicines, I would be very sick.3.My health, at present, depends on my medicines.4.My medicines protect me from becoming worse.5.My health in the future will depend on my medicines.Kebutuhan tertentu1. Hidup saya tidak akan mungkin tanpa obat obatan saya. 2. Tanpa obat-obatan, saya akan merasa sangat sakit 3. Kesehatan saya, saat ini, bergantung kepada obat-obatan saya 4. Obat-obatan saya melindungi saya dari menjadi lebih buruk 5. Kesehatan saya di masa depan akan bergantung pada obat-obatan saya Special concerns1.I sometimes worry about the longterm effects of my medications.2.Without the medicines, I would feel very ill3.My health at this time is dependent on my medicines4.My medications protect me from severity.5.My health in the future will depend on my medicationsKebutuhan tertentu1. Hidup saya tergantung pada obat obatan saya. 2. Tanpa obat-obatan, saya akan merasa sangat sakit. 3. Kesehatan saya, saat ini, bergantung kepada obat-obatan saya 4. Obat-obatan saya melindungi saya supaya tidak bertambah parah. 5. Kesehatan saya di masa depan akan bergantung pada obat-obatan saya 2.Specific concerns1.I sometimes worry about the long-term effects of my medicines.2.Having to take medicines worries me.3.I sometimes worry about becoming too dependent on my medicines.4.My medicines disrupt my life.5.My medicines are a mystery to me.Kekhawatiran tertentu1. Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya. 2. Keharusan minum obat membuat saya khawatir. 3. Saya terkadang khawatir menjadi sangat tergantung terhadap obat-obatan saya. 4. Obat-obatan saya menganggu kehidupan saya. 5. Obat-obatan saya adalah sebuah misteri bagi saya. Special concerns1.I sometimes worry about the long-term effects of my medications.2.Having to take medicine makes me worry.3.I am sometimes concerned about becoming highly dependent on my medicines.4.My medicines disrupt my life.5.My medicines are a mystery to me.Kekhawatiran tertentu1. Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya. 2. Saya khawatir karena harus minum obat. 3. Saya terkadang khawatir menjadi tergantung terhadap obat-obatan saya. 4. Obat-obatan saya menganggu kehidupan saya. 5. Saya sulit memahami obat-obatan sy. 3.General overuse1.If doctors had more time with patients, they would prescribe fewer medicines.2.Doctors use too many medicines.3.Doctors place too much trust in medicines.4.Natural remedies are safer than medicines.Penggunaan berlebihan secara umum1. Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, mereka akan meresepkan lebih sedikit obat obatan. 2. Dokter-dokter menggunakan terlalu banyak obat-obatan 3. Dokter-dokter terlalu percaya pada obat-obat 4. Pengobatan alami lebih aman dibandingkan obat-obatan Overuse1.If doctors had more time with patients, they would prescribe fewer medications.2.Doctors use too many medicines3.Doctors put too much trust in medications4.Natural treatments are safer than medicationsPenggunaan berlebihan secara umum1. Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, dokter akan meresepkan lebih sedikit obat. 2. Dokter terlalu banyak memberikan obat-obatan. 3. Dokter-dokter terlalu percaya pada obat-obat 4. Pengobatan alami lebih aman dibandingkan obat-obatan 4.General harm1.Medicines do more harm than good.2.People who take medicines should stop their treatment for a while every now and again.3.Most medicines are addictive4.All medicines are poisons.efek yang merugikan secara umum1. Obat-obatan lebih banyak merugikan daripada menguntungkan 2. Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang 3. Kebanyakan obat bersifat adiktif 4. Semua obat-obatan adalah racun Harmful effects in general1.Medicines do more harm than good2.People who take medications should stop their treatment for a while3.Most medicines are addictive4.All medicines are poisonsefek yang merugikan secara umum1.Obat-obatan lebih banyak merugikan daripada menguntungkan2.Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang3.Kebanyakan obat menyebabkan ketergantungan4.Semua obat-obatan adalah racun Forward-backward translation and pilot testing results. 1.My life would be impossible without my medicines. My life would be impossible without my medicines. 2.Without my medicines, I would be very sick. Without my medicines, I would be very sick. 3.My health, at present, depends on my medicines. My health, at present, depends on my medicines. 4.My medicines protect me from becoming worse. My medicines protect me from becoming worse. 5.My health in the future will depend on my medicines. My health in the future will depend on my medicines. 1. Hidup saya tidak akan mungkin tanpa obat obatan saya. Hidup saya tidak akan mungkin tanpa obat obatan saya. 2. Tanpa obat-obatan, saya akan merasa sangat sakit Tanpa obat-obatan, saya akan merasa sangat sakit 3. Kesehatan saya, saat ini, bergantung kepada obat-obatan saya Kesehatan saya, saat ini, bergantung kepada obat-obatan saya 4. Obat-obatan saya melindungi saya dari menjadi lebih buruk Obat-obatan saya melindungi saya dari menjadi lebih buruk 5. Kesehatan saya di masa depan akan bergantung pada obat-obatan saya Kesehatan saya di masa depan akan bergantung pada obat-obatan saya 1.I sometimes worry about the longterm effects of my medications. I sometimes worry about the longterm effects of my medications. 2.Without the medicines, I would feel very ill Without the medicines, I would feel very ill 3.My health at this time is dependent on my medicines My health at this time is dependent on my medicines 4.My medications protect me from severity. My medications protect me from severity. 5.My health in the future will depend on my medications My health in the future will depend on my medications 1. Hidup saya tergantung pada obat obatan saya. Hidup saya tergantung pada obat obatan saya. 2. Tanpa obat-obatan, saya akan merasa sangat sakit. Tanpa obat-obatan, saya akan merasa sangat sakit. 3. Kesehatan saya, saat ini, bergantung kepada obat-obatan saya Kesehatan saya, saat ini, bergantung kepada obat-obatan saya 4. Obat-obatan saya melindungi saya supaya tidak bertambah parah. Obat-obatan saya melindungi saya supaya tidak bertambah parah. 5. Kesehatan saya di masa depan akan bergantung pada obat-obatan saya Kesehatan saya di masa depan akan bergantung pada obat-obatan saya 1.I sometimes worry about the long-term effects of my medicines. I sometimes worry about the long-term effects of my medicines. 2.Having to take medicines worries me. Having to take medicines worries me. 3.I sometimes worry about becoming too dependent on my medicines. I sometimes worry about becoming too dependent on my medicines. 4.My medicines disrupt my life. My medicines disrupt my life. 5.My medicines are a mystery to me. My medicines are a mystery to me. 1. Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya. Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya. 2. Keharusan minum obat membuat saya khawatir. Keharusan minum obat membuat saya khawatir. 3. Saya terkadang khawatir menjadi sangat tergantung terhadap obat-obatan saya. Saya terkadang khawatir menjadi sangat tergantung terhadap obat-obatan saya. 4. Obat-obatan saya menganggu kehidupan saya. Obat-obatan saya menganggu kehidupan saya. 5. Obat-obatan saya adalah sebuah misteri bagi saya. Obat-obatan saya adalah sebuah misteri bagi saya. 1.I sometimes worry about the long-term effects of my medications. I sometimes worry about the long-term effects of my medications. 2.Having to take medicine makes me worry. Having to take medicine makes me worry. 3.I am sometimes concerned about becoming highly dependent on my medicines. I am sometimes concerned about becoming highly dependent on my medicines. 4.My medicines disrupt my life. My medicines disrupt my life. 5.My medicines are a mystery to me. My medicines are a mystery to me. 1. Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya. Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya. 2. Saya khawatir karena harus minum obat. Saya khawatir karena harus minum obat. 3. Saya terkadang khawatir menjadi tergantung terhadap obat-obatan saya. Saya terkadang khawatir menjadi tergantung terhadap obat-obatan saya. 4. Obat-obatan saya menganggu kehidupan saya. Obat-obatan saya menganggu kehidupan saya. 5. Saya sulit memahami obat-obatan sy. Saya sulit memahami obat-obatan sy. 1.If doctors had more time with patients, they would prescribe fewer medicines. If doctors had more time with patients, they would prescribe fewer medicines. 2.Doctors use too many medicines. Doctors use too many medicines. 3.Doctors place too much trust in medicines. Doctors place too much trust in medicines. 4.Natural remedies are safer than medicines. Natural remedies are safer than medicines. 1. Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, mereka akan meresepkan lebih sedikit obat obatan. Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, mereka akan meresepkan lebih sedikit obat obatan. 2. Dokter-dokter menggunakan terlalu banyak obat-obatan Dokter-dokter menggunakan terlalu banyak obat-obatan 3. Dokter-dokter terlalu percaya pada obat-obat Dokter-dokter terlalu percaya pada obat-obat 4. Pengobatan alami lebih aman dibandingkan obat-obatan Pengobatan alami lebih aman dibandingkan obat-obatan 1.If doctors had more time with patients, they would prescribe fewer medications. If doctors had more time with patients, they would prescribe fewer medications. 2.Doctors use too many medicines Doctors use too many medicines 3.Doctors put too much trust in medications Doctors put too much trust in medications 4.Natural treatments are safer than medications Natural treatments are safer than medications 1. Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, dokter akan meresepkan lebih sedikit obat. Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, dokter akan meresepkan lebih sedikit obat. 2. Dokter terlalu banyak memberikan obat-obatan. Dokter terlalu banyak memberikan obat-obatan. 3. Dokter-dokter terlalu percaya pada obat-obat Dokter-dokter terlalu percaya pada obat-obat 4. Pengobatan alami lebih aman dibandingkan obat-obatan Pengobatan alami lebih aman dibandingkan obat-obatan 1.Medicines do more harm than good. Medicines do more harm than good. 2.People who take medicines should stop their treatment for a while every now and again. People who take medicines should stop their treatment for a while every now and again. 3.Most medicines are addictive Most medicines are addictive 4.All medicines are poisons. All medicines are poisons. 1. Obat-obatan lebih banyak merugikan daripada menguntungkan Obat-obatan lebih banyak merugikan daripada menguntungkan 2. Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang 3. Kebanyakan obat bersifat adiktif Kebanyakan obat bersifat adiktif 4. Semua obat-obatan adalah racun Semua obat-obatan adalah racun 1.Medicines do more harm than good Medicines do more harm than good 2.People who take medications should stop their treatment for a while People who take medications should stop their treatment for a while 3.Most medicines are addictive Most medicines are addictive 4.All medicines are poisons All medicines are poisons 1.Obat-obatan lebih banyak merugikan daripada menguntungkan Obat-obatan lebih banyak merugikan daripada menguntungkan 2.Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang 3.Kebanyakan obat menyebabkan ketergantungan Kebanyakan obat menyebabkan ketergantungan 4.Semua obat-obatan adalah racun Semua obat-obatan adalah racun Validity and reliability Confirmatory Factor Analysis (CFA) is a method used to check whether survey questions match a planned structure based on theory. It examines how well each question relates to its intended idea and checks whether the overall model fits well, proving the validity of the concept. CFA was used to check the entire model, focusing on how well the questions fit and how good the model was.39 Table 3 presents the CFA findings for the specific domains, and Table 4 presents the results for the general domain.Table 3Confirmatory factor analysis results for BMQ-specific.ItemBMQ SpecificFactor12N3Kesehatan saya, saat ini, bergantung kepada obat-obatan saya0.896N2Tanpa obat-obatan, saya akan merasa sangat sakit.0.85N1Hidup saya tergantung pada obat obatan saya.0.843N5Kesehatan saya di masa depan akan bergantung pada obat-obatan saya0.82N4Obat-obatan saya melindungi saya supaya tidak bertambah parah.0.732C7Saya khawatir karena harus minum obat.0.898C8Saya terkadang khawatir menjadi tergantung terhadap obat-obatan saya.0.887C6Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya.0.697C9Obat-obatan saya menganggu kehidupan saya.0.679C10Saya sulit memahami obat-obatan sy.0.576Kaiser-Meyer-Olkin Measure of Sampling Adequacy = 0.746.Bartlett's Test of Sphericity = 0.00.Table 4Confirmatory factor analysis results for BMQ-general.ItemBMQ GeneralFactor123O11Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, dokter akan meresepkan lebih sedikit obat.0.757Dokter terlalu banyak memberikan obat-obatan.O12Dokter-dokter terlalu percaya pada obat-obat0.717O13Kebanyakan obat menyebabkan ketergantungan0.706H17Obat-obatan lebih banyak merugikan daripada menguntungkan0.459H15Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang0.745H16Pengobatan alami lebih aman dibandingkan obat-obatan0.693Semua obat-obatan adalah racunO140.646H180.668Kaiser-Meyer-Olkin Measure of Sampling Adequacy = 0.581.Bartlett's Test of Sphericity = 0.00.N1-N5: Specific Necessity, C1-C5: Specific Concerns, O1-O4: General Overuse, H1-H5: General Harm. Table 3Confirmatory factor analysis results for BMQ-specific.ItemBMQ SpecificFactor12N3Kesehatan saya, saat ini, bergantung kepada obat-obatan saya0.896N2Tanpa obat-obatan, saya akan merasa sangat sakit.0.85N1Hidup saya tergantung pada obat obatan saya.0.843N5Kesehatan saya di masa depan akan bergantung pada obat-obatan saya0.82N4Obat-obatan saya melindungi saya supaya tidak bertambah parah.0.732C7Saya khawatir karena harus minum obat.0.898C8Saya terkadang khawatir menjadi tergantung terhadap obat-obatan saya.0.887C6Saya terkadang khawatir tentang efek jangka panjang dari obat-obatan saya.0.697C9Obat-obatan saya menganggu kehidupan saya.0.679C10Saya sulit memahami obat-obatan sy.0.576Kaiser-Meyer-Olkin Measure of Sampling Adequacy = 0.746.Bartlett's Test of Sphericity = 0.00. Confirmatory factor analysis results for BMQ-specific. Kaiser-Meyer-Olkin Measure of Sampling Adequacy = 0.746. Bartlett's Test of Sphericity = 0.00. Table 4Confirmatory factor analysis results for BMQ-general.ItemBMQ GeneralFactor123O11Jika dokter-dokter mempunyai lebih banyak waktu dengan pasien, dokter akan meresepkan lebih sedikit obat.0.757Dokter terlalu banyak memberikan obat-obatan.O12Dokter-dokter terlalu percaya pada obat-obat0.717O13Kebanyakan obat menyebabkan ketergantungan0.706H17Obat-obatan lebih banyak merugikan daripada menguntungkan0.459H15Orang yang meminum obat-obatan seharusnya menghentikan pengobatannya sementara waktu, saat ini dan berulang0.745H16Pengobatan alami lebih aman dibandingkan obat-obatan0.693Semua obat-obatan adalah racunO140.646H180.668Kaiser-Meyer-Olkin Measure of Sampling Adequacy = 0.581.Bartlett's Test of Sphericity = 0.00.N1-N5: Specific Necessity, C1-C5: Specific Concerns, O1-O4: General Overuse, H1-H5: General Harm. Confirmatory factor analysis results for BMQ-general. Kaiser-Meyer-Olkin Measure of Sampling Adequacy = 0.581. Bartlett's Test of Sphericity = 0.00. N1-N5: Specific Necessity, C1-C5: Specific Concerns, O1-O4: General Overuse, H1-H5: General Harm. In addition to evaluating the factor structure, the correlation between the BMQ subscales were analysed using Pearson's correlation coefficient to assess the degree of association among the specific and general belief domains. The inter-scale correlations derived from this analysis are shown in Table 5.Table 5Pearson's correlation coefficient between scales.ItemTotal Necessity-ConcernTotal Overuse-HarmN10.6540.020N20.6320.017N30.629−0.010N40.4030.202N50.0550.633C10.0950.546C20.0570.546C30.2100.253C40.1930.523C50.2740.719O10.1320.574O20.0700.559O30.5070.126O40.5110.053H10.6090.181H20.5660.306H30.5890.231H40.4770.328N1-N5: Specific Necessity, C1-C5: Specific Concerns, O1-O4: General Overuse, H1-H5: General Harm. Table 5Pearson's correlation coefficient between scales.ItemTotal Necessity-ConcernTotal Overuse-HarmN10.6540.020N20.6320.017N30.629−0.010N40.4030.202N50.0550.633C10.0950.546C20.0570.546C30.2100.253C40.1930.523C50.2740.719O10.1320.574O20.0700.559O30.5070.126O40.5110.053H10.6090.181H20.5660.306H30.5890.231H40.4770.328N1-N5: Specific Necessity, C1-C5: Specific Concerns, O1-O4: General Overuse, H1-H5: General Harm. Pearson's correlation coefficient between scales. N1-N5: Specific Necessity, C1-C5: Specific Concerns, O1-O4: General Overuse, H1-H5: General Harm. The reliability of the BMQ was evaluated using Cronbach's alpha to assess the internal consistency of the scales. Overall Cronbach's Alpha for BMQ = 0,716, indicates acceptable internal consistency for the BMQ. Additionally, inter-rater agreement was assessed using the intraclass correlation coefficient (ICC = 0.985), to evaluate the stability and consistency of BMQ scores across different raters. The detailed results of these reliability indices and ICC inter-rater tests are presented in Table 6.Table 6BMQ questionnaire reliability and ICC inter-rater test results.Questionnaire ItemMean ± SDCorrected Item-Total CorrelationCronbach's Alpha if Item DeletedCronbach's AlphaOriginal Study Developer of BMQ (Horne et al, 1999)N12.16 ± 1.1640.8040.7790.8220,55-0,86N22.14 ± 1.1480.8090.774N32.03 ± 1.0610.8520.774N41.80 ± 0.8660.6960.804N51.97 ± 0.9000.7760.793Total Necessity10.09 ± 4.465C13.07 ± 1.2330.6200.8440.8560,63-0,80C23.40 ± 1.0560.8080.792C32.04 ± 1.0570.8060.793C42.04 ± 1.0580.6300.837C52.04 ± 1.0590.5350.863Total Concern17.29 ± 4.350O13.11 ± 0.7380.7310.6410.7240,60-0,80O22.85 ± 0.9950.5320.668O32.47 ± 0.8580.620.653O43.41 ± 0.9470.040.802Total Overuse11.84 ± 2.154H14.05 ± 0.9660.5950.7270.7690,47-0,83H23.68 ± 0.9120.7150.705H33.15 ± 1.0950.4140.765H44.24 ± 0.8430.5620.743Total Harm15.11 ± 2.607Overall Cronbach's Alpha for BMQ = 0,716.ICC Inter-rater Correlation: ICC = 0.985 (95% CI: 0.963–0.997, F = 65.006, p < 0.001). Table 6BMQ questionnaire reliability and ICC inter-rater test results.Questionnaire ItemMean ± SDCorrected Item-Total CorrelationCronbach's Alpha if Item DeletedCronbach's AlphaOriginal Study Developer of BMQ (Horne et al, 1999)N12.16 ± 1.1640.8040.7790.8220,55-0,86N22.14 ± 1.1480.8090.774N32.03 ± 1.0610.8520.774N41.80 ± 0.8660.6960.804N51.97 ± 0.9000.7760.793Total Necessity10.09 ± 4.465C13.07 ± 1.2330.6200.8440.8560,63-0,80C23.40 ± 1.0560.8080.792C32.04 ± 1.0570.8060.793C42.04 ± 1.0580.6300.837C52.04 ± 1.0590.5350.863Total Concern17.29 ± 4.350O13.11 ± 0.7380.7310.6410.7240,60-0,80O22.85 ± 0.9950.5320.668O32.47 ± 0.8580.620.653O43.41 ± 0.9470.040.802Total Overuse11.84 ± 2.154H14.05 ± 0.9660.5950.7270.7690,47-0,83H23.68 ± 0.9120.7150.705H33.15 ± 1.0950.4140.765H44.24 ± 0.8430.5620.743Total Harm15.11 ± 2.607Overall Cronbach's Alpha for BMQ = 0,716.ICC Inter-rater Correlation: ICC = 0.985 (95% CI: 0.963–0.997, F = 65.006, p < 0.001). BMQ questionnaire reliability and ICC inter-rater test results. Overall Cronbach's Alpha for BMQ = 0,716. ICC Inter-rater Correlation: ICC = 0.985 (95% CI: 0.963–0.997, F = 65.006, p < 0.001). To provide context for the findings, the internal consistency coefficients obtained in this study were compared with those reported in the original BMQ development paper and other previously validated language versions. A summary of these comparisons of alpha values across the studies is presented in Table 7.Table 7Comparisons of internal consistency (alpha values) with the original and others published in different languages.ResearchSpecific NecessitySpecific ConcernsGeneral OveruseGeneral HarmOriginal Study100,55-0,860,63-0,800,60-0,800,47-0,83Portugese190.760.67––Swedish200.8030.753––Turkish210.830.720.790.68Indonesiana.HIV patients40b.ACS patients (this study)0.560.8220.490.8560.650.7240.530.769 Table 7Comparisons of internal consistency (alpha values) with the original and others published in different languages.ResearchSpecific NecessitySpecific ConcernsGeneral OveruseGeneral HarmOriginal Study100,55-0,860,63-0,800,60-0,800,47-0,83Portugese190.760.67––Swedish200.8030.753––Turkish210.830.720.790.68Indonesiana.HIV patients40b.ACS patients (this study)0.560.8220.490.8560.650.7240.530.769 Comparisons of internal consistency (alpha values) with the original and others published in different languages. a.HIV patients40 HIV patients40 b.ACS patients (this study) ACS patients (this study) Discussion Main findings This study sought to validate the Indonesian adaptation of the Beliefs about Medicines Questionnaire (BMQ) for individuals with post-acute coronary syndrome (post-ACS) in South Sulawesi, Indonesia. The findings indicate that the BMQ is a promising instrument, demonstrating robust validity and reliability in evaluating beliefs regarding medication use. Cronbach's alpha values, ranging from 0.72 to 0.856 across various domains, suggest excellent internal consistency. These results are consistent with other BMQ validation studies conducted in different languages and clinical populations,19, 20, 21 which also reported acceptable psychometric properties of the BMQ. The achieved sample of 96 participants, as shown in the demographic data in Table 1, exceeded the minimum required sample of 90 participants based on the 5:1 subject-to-item ratio, which is commonly considered acceptable for questionnaire validation. In this study, females (58.33%) constituted a larger proportion of post-ACS patients compared to males (41.67%), which contrasts with numerous epidemiological studies where males typically exhibit a higher incidence of ACS.25, 37 This divergence may be attributed to contextual factors specific to our setting, such as health-seeking behaviours and patterns of service utilization among women. Most respondents (53.12%) were between 45 and 64 years of age, a life stage associated with an increased burden of chronic diseases and elevated cardiovascular risk. The prevalence of cardiovascular diseases, for instance, escalates from approximately 40% in individuals aged 40–59 years to around 75% in those between 60 and 79 years, ultimately reaching 86% in individuals over 80 years of age, thereby illustrating a pronounced age-dependent increase in disease burden.42 This age range coincides with the period in which, for many women, the risk of ACS rises after menopause owing to the loss of estrogen-related cardiovascular protection.43 Approximately 70% of individuals possess only an elementary to high school level of education. This finding aligns with existing evidence indicating that lower educational attainment is prevalent among Indonesian cardiac patients and is correlated with poorer health outcomes and reduced health literacy.44 Among the patients, a significant proportion were married (78.13%), suggesting that, at a group level, they may have greater access to spousal or familial support, which could influence their beliefs and perceptions regarding medication. However, it is important to recognize that marital status does not universally equate to supportive family relationships for every individual.45 The majority of patients are of Makassar ethnicity (77.08%), with a smaller Bugis ethnicity (16.67%) and others ethnicity (6.25%), reflecting the local ethnic composition of South Sulawesi and similar to regional cardiac cohorts from Makassar and Eastern Indonesia.46 The ethnic composition is significant, as ethnicity can affect language use and cultural factors, which may influence how patients comprehend and respond to the questionnaire.47, 48 The BMI distribution shows a high proportion of underweight individuals (46.88%). This is not consistent with the global pattern, where obesity and overweight are more prevalent in ACS patients.49 Approximately one-third of patients are classified as overweight or obese, consistent with the increasing prevalence of obesity as a modifiable risk factor for coronary disease, as documented in both international50 and Indonesian cohorts.51 Conversely, the relatively large proportion of patients categorized as “underweight” may suggest post-event weight loss, the presence of comorbid illnesses, or socioeconomic vulnerability. This observation may also partially reflect selection bias, given that the sample was obtained from only two hospitals in Makassar, Indonesia, which may not be fully representative of the broader post-acute coronary syndrome (ACS) population. The relatively low proportion of smokers (19.79%) contrasts with Indonesian national data, which shows a very high prevalence of smoking, especially among male.52 This difference may be due to sample bias, as the majority of respondents were female. The low prevalence of alcohol consumption (5.21%) reflects the characteristics of the Indonesian population, the majority of whom do not consume alcohol due to religious prohibitions and social stigma in Indonesian society. Second, smoking and alcohol use were self-reported and may therefore be subject to social desirability bias, whereby patients under-report socially undesirable behaviours such as smoking or drinking. This under-reporting could lead to an apparent low prevalence of these behaviours in our sample and, consequently, to an underestimation of their true contribution as risk factors in this population. Regarding the use of traditional medicine, approximately a quarter of the total respondents (26.04%) reported consuming traditional medicine. This is important because of the potential for interaction with conventional therapy,53 and the belief in traditional medicine in Indonesian culture especially in South Sulawesi, Indonesia. Socioeconomic status was not explicitly categorized, occupational data suggest that the population primarily belongs to middle-to-low income groups. The hospitals involved in the study are situated on the outskirts of Makassar, South Sulawesi, Indonesia, adjacent to surrounding regencies, and predominantly cater to patients who utilize affordable public cardiology services rather than private healthcare facilities. The response rate was 94.8%, which was significantly higher than that reported in other studies with only five patients declining to participate due to reluctance to be disturbed by questioning. In recent decades, there has been a pronounced decline in response rates for epidemiological research, with current figures often falling below 70%, a notable reduction from the over 90% achieved in the 1950s54. The small number of refusals reduces the likelihood of nonresponse bias and supports the representativeness of the sample55 for post-ACS out patients. The overall translation and adaptation workflow, including expert review and pilot testing, is summarised in Fig. 1. The Indonesian version of the BMQ was developed in accordance with established cross-cultural adaptation guidelines,33 resulting in items that are conceptually equivalent to the original while being linguistically natural and culturally appropriate for post-ACS patients. Minor wording refinements identified during pilot testing improved the clarity and acceptability of key items, particularly those describing dependence on medicines and difficulties understanding treatment. Together with the subsequent psychometric results, these findings support the cultural appropriateness, validity, and reliability of the Indonesian BMQ for assessing beliefs about medicines in this clinical setting. The translation and pilot testing led to various significant refinements that enhanced both the conceptual equivalence and comprehensibility of the Indonesian BMQ. First, domain labels were standardised (e.g. replacing “Special concerns” with “Specific concerns”) to ensure full concordance with the original factor structure. Second, item wording was naturalised while preserving underlying constructs “Hidup saya tidak akan mungkin tanpa obat obatan saya” to “Hidup saya tergantung pada obat obatan saya” and “Obat-obatan saya adalah sebuah misteri bagi saya” to “ Saya sulit memahami obat-obatan saya”. These changes reflect the cultural adaptation necessary to ensure proper understanding in the Indonesian context. The CFA results indicate that the specific BMQ items form a clear two-factor structure (necessity and concerns) with good factor loadings and adequate sampling adequacy as shown in Table 3. Factor 1 (Necessity items N1–N5) shows very high loadings (0.732–0.896), indicating that all necessity items strongly represent the latent “specific necessity” construct. Factor 2 (Concern items C6–C10) also has substantial loadings (0.576–0.898), supporting a coherent “specific concerns” factor, although item C10 (“Saya sulit memahami obat-obatan saya”) has the lowest loading (0.576) and reflects a relatively weaker, but still acceptable, association with the latent construct. For the general BMQ domain, the CFA suggested a three-factor structure with mostly acceptable item loadings but weaker overall sampling adequacy. Factor 1 grouped the general overuse items: “dokter akan meresepkan obat lebih …,” “dokter menggunakan lebih banyak obat-obatan”, and “dokter tterlalu percaya pada obat-obat”, with loadings of 0.757, 0.717, and 0.706, respectively, indicating a well-defined overuse construct. Factor 2 contained items reflecting general harm/addiction: “most medicines cause dependence” and “medicines do more harm than good”, with moderate loadings of 0.745 and 0.693. Factor 3 included “people should stop treatment for a while” and “all medicines are poisons”, with loadings of 0.646 and 0.668, representing a more extreme harmful/poison belief dimension. The KMO value of 0.581 indicates marginal sampling adequacy, suggesting that while correlations among general-domain items are present, they are not particularly strong. Consequently, the model demonstrates less robustness compared to the specific domain. The significant result of Bartlett's test (p = 0.00) confirms the suitability of the correlation matrix for factor analysis, indicating that the extracted factors are statistically meaningful. Pearson's correlation coefficient between scales as shown in Table 5, was used to quantify the strength and direction of the linear association between each item score and the corresponding composite scale score. Most items show statistically significant and theoretically coherent correlations with their respective composite scales. Necessity items N1–N4 are strongly correlated with the Total Necessity–Concern score (r ≈ 0.40–0.65), indicating they robustly represent patients' perceived need for medicines. Concern/overuse/harm items C1, C2, C4, C5, O1, O2, and N5 correlate strongly with the Total Overuse–Harm score (r ≈ 0.52–0.72), confirming that they capture negative or skeptical beliefs about medicines as intended. The Necessity-Concerns Framework Horne et al., 1999, which underscores the equilibrium between patients' beliefs regarding the necessity of their medication and their apprehensions about potential side effects, offers a valuable perspective for interpreting the results of the BMQ validity test. The results of the BMQ validity test show that all 18 items in the four domains (Specific Necessity, Specific Concerns, General Overuse, and General Harm) have a correlation coefficient (r) greater than the r-table value (0.1996), indicating excellent validity. The validity of all BMQ items is consistent with the research by Kumar et al.56 who validated the BMQ in Hindi. In this study, all items also demonstrated good validity, with factor loadings ranging from 0.660 to 0.817. Most items show statistically significant and theoretically coherent correlations with their respective composite scales. Necessity items N1–N4 are strongly correlated with the Total Necessity–Concern score (r ≈ 0.40–0.65), indicating they robustly represent patients' perceived need for medicines. Concern/overuse/harm items C1, C2, C4, C5, O1, O2, and N5 correlate strongly with the Total Overuse–Harm score (r ≈ 0.52–0.72), confirming that they capture negative or skeptical beliefs about medicines as intended. Table 6, Comparison with Kumar et al. (2022) research shows good consistency, where BMQ-Hindi has a Cronbach's alpha of 0.79 for the ‘necessity’ domain and 0.63 for the ‘concerns’ domain. The original study by BMQ developers Horne et al. reported a Cronbach's alpha range of 0.55–0.86 for various medical conditions; therefore, the results of this study fall within an acceptable range. The General Overuse domain showed the lowest reliability (α = 0.724), which may indicate that perceptions of overuse of medication by doctors vary in the Indonesian context, possibly influenced by the level of public trust in the treatment received. This shows that patients' perceptions of medical services and treatment still vary greatly. The mean scores on the General Harm and General Overuse subscales were notably high. Items such as “all medicines are poisons” and “medicines do more harm than good” scored above 4 on a 5-point scale, indicating extremely negative perceptions of medications. This pattern is more pronounced than in previous Indonesian studies utilising the BMQ among pregnant women,22 where General Harm and Overuse scores were in the low-to-moderate negative range, although higher harm beliefs were still linked to poorer adherence. The heightened negativity observed in the current study may reflect the clinical context of post-ACS patients who frequently receive multiple long-term medications. It may also be influenced by cultural perceptions of medicines as inherently ‘strong’ or potentially toxic, translation nuances that amplify the negative tone of the items, or acquiescence and sampling bias. These findings suggest that the Indonesian BMQ General scale is effective in detecting negative beliefs about medicines, supporting construct validity. However, they also underscore the necessity for further research in other Indonesian populations to determine whether such extreme scores are specific to post-ACS patients or are more broadly generalisable. The notably high General Harm and Overuse scores (mean > 4/5) underscore a significant opportunity for pharmacists in post-ACS care. The utilization of the BMQ during medication reviews can identify patients with markedly negative beliefs, such as the perception that “all medicines are poisons”. This identification enables targeted interventions, including addressing cultural perceptions of medicines as ‘strong/toxic’ through patient education on evidence-based benefits versus actual risks. Such interventions can enhance medication adherence in this high-risk group. The validation of the Indonesian BMQ in this study demonstrates superior reliability (α: Necessity 0.822, Concerns 0.856, Overuse 0.724, Harm 0.769) compared to previous data as shown in Table 7. This finding confirms its psychometric robustness for post-ACS adherence screening in resource-limited settings. The comparative reliability indicate that the Indonesian BMQ validation for post-ACS patients in this study achieved superior Cronbach's α values across all subscales: Specific Necessity (0.822), Specific Concerns (0.856), General Overuse (0.724), and General Harm (0.769). These values surpass those reported in the original study (0.55–0.86),10 as well as in the Portuguese (0.76/0.67),19 Swedish (0.803/0.753/0.79/0.68),20 Turkish (0.83/0.72),21 and previous Indonesian HIV validation studies (0.56/0.49/0.65/0.53).40 This confirms the excellent psychometric robustness and cultural applicability of the instrument for routine clinical adherence screening in Indonesian cardiovascular care settings. While the findings indicate that the BMQ is effective in evaluating medication beliefs within this population, additional psychometric assessments are necessary to verify its broader applicability and generalizability across diverse regions and patient populations. The study's small, non-probability sample and regional focus constrain the generalizability of the results to a national level. Future research should incorporate larger and more diverse samples to enhance the external validity of the instrument. The Beliefs about Medicines Questionnaire (BMQ) can assist pharmacists in identifying patients at elevated risk of non-adherence, particularly those who express significant concerns regarding medication side effects or potential overuse.41 This insight can inform pharmacists' counseling strategies, enabling them to deliver patient-centered care that not only enhances medication adherence but also supports long-term health outcomes. We assert that, with further validation, the BMQ has the potential to become an integral tool in routine clinical practice, especially in cardiology follow-up and other domains where patient beliefs substantially influence treatment outcomes. Strenghts and limitations This study represents the first effort to translate, culturally adapt, and psychometrically evaluate the BMQ specifically for patients with cardiovascular disease, particularly those post-ACS, in Makassar, Indonesia. This study provides novel data from a population that has been relatively understudied. The Indonesian BMQ demonstrated acceptable construct validity and internal consistency, suggesting that the instrument is appropriate for assessing beliefs about medicines in post-ACS patients treated at two hospitals in this region of Indonesia. Furthermore, it can serve as a foundation for future clinical and adherence studies in similar Indonesian contexts. Limitation: The small sample size and the non-random sampling method constrain the generalizability of the findings. Furthermore, the assistance provided to some patients in completing the questionnaires may have introduced bias, particularly among patients with lower literacy levels. These limitations underscore the necessity for future research employing larger randomized samples and further psychometric testing to validate the BMQ across diverse healthcare settings. Conclusion The Indonesian adaptation of the Beliefs about Medicines Questionnaire (BMQ) demonstrates promising validity and reliability for assessing the perceptions of patients with post-acute coronary syndrome (ACS) treated at two hospitals in South Sulawesi, Indonesia. These results indicate that the tool could benefit the evaluation of treatment beliefs in this group, supporting pharmacist-led adherence interventions in routine post-ACS care (e.g. identifying necessity-concerns imbalances during medication reviews) and informing educational programs targeting belief modification. Additional psychometric assessments are needed to verify its wider applicability and generalisability to other regions and patient populations in the future. CRediT authorship contribution statement Zulkifli Halid: Writing – review & editing, Writing – original draft, Resources, Investigation, Formal analysis, Data curation. Dyah Aryani Perwitasari: Writing – review & editing, Writing – original draft, Supervision, Project administration, Methodology, Funding acquisition, Conceptualization. Nanik Sulistyani: Writing – review & editing, Writing – original draft, Visualization, Supervision, Resources, Project administration, Formal analysis, Conceptualization. Imaniar Noor Faridah: Writing – review & editing, Writing – original draft, Validation, Supervision, Methodology, Funding acquisition, Formal analysis. lham Alifiar: Writing – review & editing, Writing – original draft, Validation, Software, Data curation, Conceptualization. Thang Nguyen: Writing – review & editing, Writing – original draft, Supervision, Software, Resources, Methodology, Formal analysis, Data curation. Declaration of competing interest The author(s) report no conflicts of interest in this work.